These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34473341)

  • 1. More than skin deep: a survey of real-life experiences of acne vulgaris.
    Ra AG; Ho B; Bickerstaffe L; Bewley A
    Br J Dermatol; 2022 Jan; 186(1):191-193. PubMed ID: 34473341
    [No Abstract]   [Full Text] [Related]  

  • 2. Perceptions and psychosocial judgement of patients with acne vulgaris.
    Loh KC; Chan LC; Phang LF
    Med J Malaysia; 2020 Jan; 75(1):18-23. PubMed ID: 32008014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of skin care and makeup under instructions from dermatologists on the quality of life of female patients with acne vulgaris.
    Matsuoka Y; Yoneda K; Sadahira C; Katsuura J; Moriue T; Kubota Y
    J Dermatol; 2006 Nov; 33(11):745-52. PubMed ID: 17073988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Assessment of Efficacy and Safety in Patients Aged 9 Years and Older.
    Tyring SK; Kircik LH; Pariser DM; Guenin E; Bhatt V; Pillai R
    J Drugs Dermatol; 2018 Oct; 17(10):1084-1091. PubMed ID: 30365589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of Silicol Skin on moderate to severe acne: UK field survey.
    Acne Support Group
    Adv Ther; 2001; 18(2):93-9. PubMed ID: 11446273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Impact of Gender and Race on Efficacy and Safety.
    Lain E; Day D; Harper J; Guenin E
    J Drugs Dermatol; 2019 Nov; 18(11):1128-1138. PubMed ID: 31741356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study on efficacy treatment of acne vulgaris using a new method: results of a randomized double-blind trial with Acne Dressing.
    Chao CM; Lai WY; Wu BY; Chang HC; Huang WS; Chen YF
    J Cosmet Sci; 2006; 57(2):95-105. PubMed ID: 16688374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel microgel complex delivers acne medicine deep into follicles while demonstrating high patient tolerance.
    Wu J; Chantalat J; Liu JC
    J Drugs Dermatol; 2015 Feb; 14(2):176-82. PubMed ID: 25689813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin surface glycerol levels in acne vulgaris.
    Rebillo T; Hawk JL
    J Invest Dermatol; 1978 Jun; 70(6):352-4. PubMed ID: 148480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digital videography assessment of patients' experiences using adapalene-benzoyl peroxide gel in the treatment of acne vulgaris.
    Feldman SR; Fried RG; Herndon JH; Johnson L; Preston N; Gottschalk RW; Caveney SW
    J Drugs Dermatol; 2012 Aug; 11(8):919-25. PubMed ID: 22859236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acne vulgaris. Role of cosmetics].
    Korting HC; Borelli C; Schöllmann C
    Hautarzt; 2010 Feb; 61(2):126-31. PubMed ID: 20107752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adapalene gel 0.1% for topical treatment of acne vulgaris in African patients.
    Jacyk WK; Mpofu P
    Cutis; 2001 Oct; 68(4 Suppl):48-54. PubMed ID: 11845948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Open Label, Phase 2 Study of MABp1 Monotherapy for the Treatment of Acne Vulgaris and Psychiatric Comorbidity.
    Carrasco D; Stecher M; Lefebvre GC; Logan AC; Moy R
    J Drugs Dermatol; 2015 Jun; 14(6):560-4. PubMed ID: 26091380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral treatment of acne vulgaris and oil acne with tetracycline.
    Czernielewski A; Skwarczyńska-Banyś E
    Dermatologica; 1982 Jul; 165(1):62-5. PubMed ID: 6214437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of acne vulgaris and its impact of the quality of life among secondary school-aged adolescents in Sohag Province, Upper Egypt.
    El-Hamd MA; Nada EEA; Moustafa MA; Mahboob-Allah RA
    J Cosmet Dermatol; 2017 Sep; 16(3):370-373. PubMed ID: 28256050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of tazarotene cream 0.1% after a single dose and after repeat topical applications at clinical or exaggerated application rates in patients with acne vulgaris or photodamaged skin.
    Yu Z; Sefton J; Lew-Kaya D; Walker P; Yu D; Tang-Liu DD
    Clin Pharmacokinet; 2003; 42(10):921-9. PubMed ID: 12885265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acne vulgaris and the quality of life of adult dermatology patients.
    Lasek RJ; Chren MM
    Arch Dermatol; 1998 Apr; 134(4):454-8. PubMed ID: 9554297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of two anti-acne/anti-aging treatments in subjects with photodamaged skin and mild to moderate acne vulgaris.
    Kircik LH; Dahl A; Yatskayer M; Raab S; Oresajo C
    J Drugs Dermatol; 2012 Jun; 11(6):737-40. PubMed ID: 22648221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of continuous high versus low dose oral isotretinoin regimens on dermcidin expression in patients with moderate to severe acne vulgaris.
    El Aziz Ragab MA; Omar SS; Collier A; El-Wafa RAHA; Gomaa N
    Dermatol Ther; 2018 Nov; 31(6):e12715. PubMed ID: 30397984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tazarotene 0.045% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Results from Two Phase 3 Trials.
    Tanghetti EA; Werschler WP; Lain T; Guenin E; Martin G; Pillai R
    J Drugs Dermatol; 2020 Jan; 19(1):70-77. PubMed ID: 31985914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.